Inhibition of the Phosphatidylinositol 3′–Kinase Signaling Pathway Increases the Responsiveness of Pancreatic Carcinoma Cells to Sulindac
- 1 March 2003
- journal article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 7 (3) , 354-363
- https://doi.org/10.1016/s1091-255x(02)00156-7
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites.2001
- Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells.2000
- Cyclooxygenase-2 expression in human pancreatic adenocarcinomasCarcinogenesis: Integrative Cancer Research, 2000
- Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.1999
- The Role of Cyclooxygenase Inhibition in the Antineoplastic Effects of Nonsteroidal Antiinflammatory Drugs (Nsaids)The Journal of Experimental Medicine, 1999
- Sulindac sulfide alters the expression of cyclin proteins in HT-29 colon adenocarcinoma cellsInternational Journal of Cancer, 1998
- Caspase-dependent Cleavage of Signaling Proteins during ApoptosisPublished by Elsevier ,1998
- Signal Transduction through MAP Kinase CascadesPublished by Elsevier ,1998
- Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells.Journal of Clinical Investigation, 1995
- Aspirin, NSAIDs, and digestive tract cancersCancer and Metastasis Reviews, 1994